Liver transplant bleeding study pulled before starting
NCT ID NCT06764927
First seen May 21, 2026 · Last updated May 24, 2026 · Updated 1 time
Summary
This study was designed to see if a new clotting medicine works better than the standard one for controlling bleeding in liver transplant patients. It planned to include adults having a liver transplant who were at risk of bleeding problems. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANT SURGERY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UPMC Montefiore Hospital
Pittsburgh, Pennsylvania, 15213, United States
-
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania, 15213, United States
-
University of Cincinnati
Cincinnati, Ohio, 45221, United States
Conditions
Explore the condition pages connected to this study.